Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-di… read more
Healthcare
Drug Manufacturers—Specialty & Generic
1 years
USD
Exclusive to Premium users
$0.99
Price+0.57%
$0.00
$10.568m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$39.181m
-
1y CAGR-
3y CAGR-
5y CAGR-$16.592m
-
1y CAGR-
3y CAGR-
5y CAGR$0.66
-
1y CAGR-
3y CAGR-
5y CAGR-$4.668m
$20.142m
Assets$24.810m
Liabilities$5.004m
Debt24.8%
-0.3x
Debt to EBITDA-$9.342m
-
1y CAGR-
3y CAGR-
5y CAGR